免疫測定分析装置市場：製品別、用途別-2025～2030年の世界予測

免疫測定分析装置市場は、2023年に121億5,000万米ドルと評価され、2024年には127億2,000万米ドルに達すると予測され、CAGR 6.92%で成長し、2030年には194億3,000万米ドルになると予測されています。

免疫測定分析装置による生物医療研究や診断検査において、生物学的マーカーの正確な検出と定量化は極めて重要です。この市場には、病院、研究所、診断センターなど、タイプ、用途、エンドユーザー別にセグメント化された自動分析装置と手動分析装置が含まれます。これらの分析装置は、疾病管理、治療モニタリング、個別化医療における診断に極めて重要です。慢性疾患の増加、高齢化、バイオテクノロジーの進歩は市場成長の大きな促進要因です。個別化医療に対する需要の増加と免疫測定技術の進歩も市場を促進します。主要ビジネス機会は、これらの分析装置にAIと機械学習を統合し、予測分析能力と効率を高めること、また、より身近な医療ソリューションを求める消費者の需要によって急成長している在宅検査市場を開拓することです。しかし、市場は先進的な免疫測定分析装置の高コストや複雑な規制環境といった課題に直面しており、これが市場浸透や技術採用を遅らせる要因となっています。さらに、発展途上地域では、専門的な操作スキルの必要性が障壁となることもあります。これらを克服するためには、費用対効果に優れ、ユーザーフレンドリーな機器と堅牢な分析技術に焦点を当てたイノベーションが極めて重要です。企業は、必要性がますます高まっているポイントオブケア検査に適した、低コストのバイオセンサーやポータブル免疫測定装置の開発をさらに追求すべきです。研究の観点からは、ナノ技術やマイクロ流体工学を統合した次世代イムノアッセイプラットフォームを探求することで、感度と精度の向上が期待できます。さらに、バイオテクノロジー企業との戦略的提携や協力関係により、迅速な技術統合と市場拡大が可能になります。市場は競争的で進化しており、多様化する医療現場のニーズに対応するためのイノベーションに対する需要は旺盛です。そのため、技術的なブレークスルーと適応戦略に注力することで、市場での大きな存在感と事業の成長を切り開くことができます。

市場力学：急速に進化する免疫測定分析装置市場の主要市場洞察を公開

免疫測定分析装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • がん領域におけるイムノアッセイの高い需要
  • イムノアッセイをベースとしたポイントオブケア検査と迅速検査の普及の高まり
  • 薬剤・アルコール検査を義務付ける厳しい規制
• 市場抑制要因
  • 不利な償還施策
  • 厳しい承認規制
• 市場機会
  • 微生物ベースの感染症を診断するための免疫測定分析装置の絶え間ない開発
  • 先端技術の統合と製品の改良
• 市場課題
  • 免疫測定分析装置の誤読

ポーターのファイブフォース：免疫測定分析装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、免疫測定分析装置市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：免疫測定分析装置市場における外部からの影響の把握

外部マクロ環境要因は、免疫測定分析装置市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：免疫測定分析装置市場における競合情勢の把握

免疫測定分析装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：免疫測定分析装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、免疫測定分析装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：免疫測定分析装置市場における成功への道筋を描く

免疫測定分析装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 腫瘍学における免疫測定法の使用に対する高い需要
    • 免疫測定法によるポイントオブケア検査と迅速検査の普及率の上昇
    • 薬剤とアルコールの検査を義務付ける厳しい規制
  • 抑制要因
    • 不利な払い戻し施策
    • 承認に関する厳格な規制
  • 機会
    • 微生物による感染症を診断するための免疫測定分析装置の継続的な開発
    • 先進技術の統合と製品の改善
  • 課題
    • 免疫測定分析装置の誤った読み方
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 免疫測定分析装置市場：製品別

• イントロダクション
• 化学発光免疫測定法
• 消耗品と付属品
• 酵素免疫測定法
• 免疫蛍光分析装置
• 放射免疫測定

第7章 免疫測定分析装置市場：用途別

• イントロダクション
• 自己免疫疾患
• 心臓病学
• 内分泌学
• 感染症検査
• 腫瘍学
• 治療モニタリング

第8章 南北アメリカの免疫測定分析装置市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の免疫測定分析装置市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの免疫測定分析装置市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Beckman Coulter, Inc.
• Becton Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Boditech Med Inc.
• DiaSorin S.p.A.
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• Ortho-Clinical Diagnostics, Inc.
• Quidel Corporation
• Siemens Healthineers AG
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• WAK-Chemie Medical GmbH

LIST OF FIGURES

• FIGURE 1. IMMUNOASSAY ANALYZERS MARKET RESEARCH PROCESS
• FIGURE 2. IMMUNOASSAY ANALYZERS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. IMMUNOASSAY ANALYZERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. IMMUNOASSAY ANALYZERS MARKET DYNAMICS
• TABLE 7. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. CANADA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. CANADA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. AUSTRALIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AUSTRALIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. CHINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. CHINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. INDIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. INDIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. INDONESIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. INDONESIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. JAPAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. JAPAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MALAYSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. MALAYSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. PHILIPPINES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. PHILIPPINES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. SINGAPORE IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. SINGAPORE IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. SOUTH KOREA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. SOUTH KOREA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. TAIWAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. TAIWAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. THAILAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. THAILAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. VIETNAM IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. VIETNAM IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. DENMARK IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. DENMARK IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. EGYPT IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. EGYPT IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. FINLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. FINLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. FRANCE IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. FRANCE IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. GERMANY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. GERMANY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ISRAEL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. ISRAEL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. ITALY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. ITALY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. NETHERLANDS IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. NETHERLANDS IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. NIGERIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. NIGERIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. NORWAY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. NORWAY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. POLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. POLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. QATAR IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. QATAR IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. RUSSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. RUSSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SAUDI ARABIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SAUDI ARABIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SPAIN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. SPAIN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. SWEDEN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. SWEDEN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. SWITZERLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. SWITZERLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. TURKEY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. TURKEY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. UNITED ARAB EMIRATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. UNITED ARAB EMIRATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. UNITED KINGDOM IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. UNITED KINGDOM IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 107. IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

The Immunoassay Analyzers Market was valued at USD 12.15 billion in 2023, expected to reach USD 12.72 billion in 2024, and is projected to grow at a CAGR of 6.92%, to USD 19.43 billion by 2030.

Immunoassay analyzers are crucial in biomedical research and diagnostic testing, offering precise detection and quantification of biological markers. The scope of this market includes automated and manual analyzers segmented by type, application, and end-user, such as hospitals, research labs, and diagnostic centers. These analyzers are pivotal for diagnostics in disease management, therapeutic drug monitoring, and personalized medicine. The growing prevalence of chronic diseases, an aging population, and advances in biotechnology are significant drivers for market growth. Increasing demand for personalized medicine and advancements in immunoassay technology also propel the market. Key opportunities emerge with the integration of AI and machine learning in these analyzers, enhancing predictive analytics capabilities and efficiency, as well as tapping into the burgeoning home testing market driven by consumer demands for more accessible healthcare solutions. However, the market faces challenges such as high costs of advanced immunoassay analyzers and complex regulatory environments, which can slow down market penetration and technology adoption. Additionally, the need for specialized operating skills can be a barrier in developing regions. To overcome these, innovations focusing on cost-effective, user-friendly devices, and robust analytical technologies are crucial. Companies should further explore developing low-cost biosensors and portable immunoassay devices suitable for point-of-care testing, which is increasingly becoming a necessity. From a research standpoint, exploring next-generation immunoassay platforms that integrate nanotechnology or microfluidics could enhance sensitivity and accuracy. Furthermore, strategic collaborations and partnerships with biotechnology firms can facilitate quicker technology integration and market expansion. The market is competitive, evolving, with robust demand for innovation to meet the growing needs of diverse healthcare settings. Therefore, focusing on technological breakthroughs and adaptive strategies can carve out significant market presence and business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoassay Analyzers Market

The Immunoassay Analyzers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High demand for use of immunoassays in oncology
  • Rising penetration of immunoassay-based point-of-care testing and rapid testing
  • Stringent regulation mandating drug and alcohol testing
• Market Restraints
  • Unfavorable reimbursement policies
  • Stringent regulation for approvals
• Market Opportunities
  • Constant development of immunoassay analyzers to diagnose microorganism-based infections
  • Integration of advanced technologies and product improvements
• Market Challenges
  • False readings in immunoassay analyzers

Porter's Five Forces: A Strategic Tool for Navigating the Immunoassay Analyzers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoassay Analyzers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoassay Analyzers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoassay Analyzers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoassay Analyzers Market

A detailed market share analysis in the Immunoassay Analyzers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoassay Analyzers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoassay Analyzers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoassay Analyzers Market

A strategic analysis of the Immunoassay Analyzers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoassay Analyzers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Boditech Med Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Merck KGaA, Ortho-Clinical Diagnostics, Inc., Quidel Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and WAK-Chemie Medical GmbH.

Market Segmentation & Coverage

This research report categorizes the Immunoassay Analyzers Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay, Immunofluorescence Analyzers, and Radioimmunoassay.
• Based on Application, market is studied across Autoimmune Disease, Cardiology, Endocrinology, Infectious Disease Testing, Oncology, and Therapeutic Drug Monitoring.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High demand for use of immunoassays in oncology
    • 5.1.1.2. Rising penetration of immunoassay-based point-of-care testing and rapid testing
    • 5.1.1.3. Stringent regulation mandating drug and alcohol testing
  • 5.1.2. Restraints
    • 5.1.2.1. Unfavorable reimbursement policies
    • 5.1.2.2. Stringent regulation for approvals
  • 5.1.3. Opportunities
    • 5.1.3.1. Constant development of immunoassay analyzers to diagnose microorganism-based infections
    • 5.1.3.2. Integration of advanced technologies and product improvements
  • 5.1.4. Challenges
    • 5.1.4.1. False readings in immunoassay analyzers
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Immunoassay Analyzers Market, by Product

• 6.1. Introduction
• 6.2. Chemiluminescence Immunoassay
• 6.3. Consumables & Accessories
• 6.4. Enzyme-linked Immunoassay
• 6.5. Immunofluorescence Analyzers
• 6.6. Radioimmunoassay

7. Immunoassay Analyzers Market, by Application

• 7.1. Introduction
• 7.2. Autoimmune Disease
• 7.3. Cardiology
• 7.4. Endocrinology
• 7.5. Infectious Disease Testing
• 7.6. Oncology
• 7.7. Therapeutic Drug Monitoring

8. Americas Immunoassay Analyzers Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Immunoassay Analyzers Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Immunoassay Analyzers Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Beckman Coulter, Inc.
• 3. Becton Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. bioMerieux SA
• 6. Boditech Med Inc.
• 7. DiaSorin S.p.A.
• 8. F. Hoffmann-La Roche Ltd.
• 9. Merck KGaA
• 10. Ortho-Clinical Diagnostics, Inc.
• 11. Quidel Corporation
• 12. Siemens Healthineers AG
• 13. Sysmex Corporation
• 14. Thermo Fisher Scientific Inc.
• 15. WAK-Chemie Medical GmbH